Advertisement
News
Subscribe to MDT Magazine News

How to Stick to New Year's Resolutions

January 3, 2011 4:50 am | Comments

Social media, Wi-Fi gadgets and a sense of shame keep people motivated.

Acetadote (acetylcysteine) Injection: Recall - Particulate Matter Found in a Small Number of Vials

January 3, 2011 4:50 am | Comments

6 lots of Acetadote is being recalled as a precautionary measure based on observed particulate matter found in a small number of vials.

Lincare board declares regular 20-cent dividend

January 3, 2011 4:45 am | by The Associated Press | Comments

Lincare Holdings Inc., which provides home delivery of oxygen and respiratory therapies, said Monday its board of directors declared a quarterly cash dividend of 20 cents per share.The dividend is payable on Jan. 28 to stockholders of record as of Jan. 14.

Advertisement

Caraco Pharmaceutical Laboratories, Ltd. Provides Update on Remediation Activities

January 3, 2011 4:34 am | by Bio-Medicine.Org | Comments

DETROIT, Jan. 3, 2011 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) announced that based on remediation efforts to date, it does not expect to commence the manufacture and distribution of products from its Detroit facility by the end of Caraco's Fiscal Year 2011, ending...

TOPICS:

Accuray Elevated to NASDAQ Global Select Market

January 3, 2011 4:33 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Jan. 3, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that it has been named to the NASDAQ Global Select Market, the premier listing tier for NASDAQ companies. The NASDAQ Global Select Market is designated...

TOPICS:

Advanced Life Sciences to Explore Strategic Alternatives to Maximize Shareholder Value

January 3, 2011 4:33 am | by Bio-Medicine.Org | Comments

CHICAGO, Jan. 3, 2011 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that...

TOPICS:

Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital

January 3, 2011 4:32 am | by Bio-Medicine.Org | Comments

RARITAN, N.J., Jan. 3, 2011 /- Veridex, LLC (Veridex) today announced a collaboration with Massachusetts General Hospital to develop and commercialize a next-generation circulating tumor cell (CTC) technology for capturing, counting and characterizing tumor cells found in patients'...

TOPICS:

Smith & #38; Nephew Receives Warning Citing Quality Control Failures

December 31, 2010 5:31 pm | by U.S. Food & Drug Administration | Comments

Quality control issues involving Smith & Nephew’s ceramic acetabular hip implants have resulted in a warning letter.

TOPICS:
Advertisement

Devicemakers Question Value of CMS, FDA Parallel Review

December 31, 2010 5:30 pm | by U.S. Food & Drug Administration | Comments

Despite claims by the FDA and Centers for Medicare & Medicaid Services (CMS) that parallel review could expedite marketing of new devices, industry fears the opposite could happen, depending on how the program is implemented.

TOPICS:

Complaints and Concerns about Medicare Competitive Bidding for Home Medical Equipment Can Be Reported Via a Toll-Free Number and Website

December 31, 2010 10:33 am | by Bio-Medicine.Org | Comments

WASHINGTON, Dec. 31, 2010 /PRNewswire-USNewswire/ -- On January 1, 2011, Medicare starts a new "competitive bidding" program for durable medical equipment and supplies in nine metropolitan regions: Charlotte, Cincinnati, Cleveland, Dallas-Fort Worth, Kansas City, Miami, Orlando,...

TOPICS:

Lotus Pharmaceuticals Announces Approval of Reverse Stock Split

December 31, 2010 7:35 am | by Bio-Medicine.Org | Comments

BEIJING, Dec. 31, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that the...

TOPICS:

Sinovac's Stock Exchange Listing Moves to NASDAQ Global Select Market

December 31, 2010 4:36 am | by Bio-Medicine.Org | Comments

BEIJING, Dec. 31, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading provider of biopharmaceutical products in China, announced today its common shares will be listed on the NASDAQ Global Select Market effective January 3, 2011.  The Company received...

TOPICS:

CVS CAREMARK to Purchase Universal American's Medicare Part D Business

December 31, 2010 4:36 am | by Bio-Medicine.Org | Comments

WOONSOCKET, R.I., Dec. 31, 2010 /- CVS Caremark (NYSE: CVS ) today announced it has entered into an agreement to acquire the Medicare Part D business of Universal American (NYSE: UAM ) for approximately $1.25 billion.  Universal American is a leading Medicare Prescription Drug...

TOPICS:

Unilife Receives SPP Applications Exceeding A$12.8 Million

December 31, 2010 4:35 am | by Bio-Medicine.Org | Comments

LEWISBERRY, Pa., Dec. 31, 2010 /- Unilife Corporation ( Unilife or Company ) (Nasdaq: UNIS ; ASX: UNS) announced today that its 2010 Share Purchase Plan ( SPP ), which closed on Wednesday, 22 December 2010, was significantly oversubscribed. The Company has received applications for...

TOPICS:

Clinical Data completes $15.5M unit sale

December 30, 2010 9:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Newton drug developer Clinical Data Inc. has completed the $15.5 million sale of its pharmacogenomics and biomarker development business to Transgenomic Inc. of Omaha, Neb.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading